Join
Live feed
·
INSIDERFilingvia Quantisnow
ImmunityBio Inc. logo

Director Simon Barry J. sold $165,306 worth of shares (23,033 units at $7.18) as part of a pre-agreed trading plan, decreasing direct ownership by 0.81% to 2,827,788 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IBRX· ImmunityBio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IBRX (ImmunityBio Inc.) and more on Quantisnow.